Singapore markets closed

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
94.86+0.07 (+0.07%)
At close: 04:00PM EDT
94.86 0.00 (0.00%)
After hours: 04:11PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.80B
Enterprise value 5.43B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)23.02
Price/book (mrq)44.44
Enterprise value/revenue 21.76
Enterprise value/EBITDA -11.54

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3114.02%
S&P500 52-week change 329.57%
52-week high 3101.00
52-week low 341.54
50-day moving average 385.84
200-day moving average 367.29

Share statistics

Avg vol (3-month) 3814.91k
Avg vol (10-day) 3893.93k
Shares outstanding 561.23M
Implied shares outstanding 661.23M
Float 860.55M
% held by insiders 10.88%
% held by institutions 1106.50%
Shares short (15 Mar 2024) 45.15M
Short ratio (15 Mar 2024) 45.2
Short % of float (15 Mar 2024) 411.31%
Short % of shares outstanding (15 Mar 2024) 48.41%
Shares short (prior month 15 Feb 2024) 44.63M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -203.30%
Operating margin (ttm)-146.07%

Management effectiveness

Return on assets (ttm)-25.34%
Return on equity (ttm)-157.13%

Income statement

Revenue (ttm)249.38M
Revenue per share (ttm)4.12
Quarterly revenue growth (yoy)85.50%
Gross profit (ttm)N/A
EBITDA -474.61M
Net income avi to common (ttm)-506.98M
Diluted EPS (ttm)-8.37
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)710.64M
Total cash per share (mrq)11.61
Total debt (mrq)774.12M
Total debt/equity (mrq)592.70%
Current ratio (mrq)3.76
Book value per share (mrq)2.14

Cash flow statement

Operating cash flow (ttm)-436.85M
Levered free cash flow (ttm)-239.41M